-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AilMi9fBwvdZaG5lgFMUfOFjc0wyg6NVHRpjzAghfoXh/sWDQMQOy4rUs8z5fFFb 9ZUiQq8AJ7Kz+KPwVZxunQ== 0000950135-00-000647.txt : 20000214 0000950135-00-000647.hdr.sgml : 20000214 ACCESSION NUMBER: 0000950135-00-000647 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000211 GROUP MEMBERS: ANNETTE BAUMGARTNER GROUP MEMBERS: BAUMGARTNER WERNER A SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-39145 FILM NUMBER: 533987 BUSINESS ADDRESS: STREET 1: 1280 MASSACHUSETTS AVENUE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6178687455 MAIL ADDRESS: STREET 1: 1280 MASSACHUSETTS AVE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAUMGARTNER WERNER A CENTRAL INDEX KEY: 0000900595 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5832 UPLANDER WAY CITY: CULVER CITY STATE: CA ZIP: 90230 BUSINESS PHONE: 3102167776 MAIL ADDRESS: STREET 1: 5832 UPLANDER WAY CITY: CULVER CITY STATE: CA ZIP: 90230 SC 13G/A 1 WERNER A. BAUMGARTNER 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12) PSYCHEMEDICS CORPORATION ----------------------------------------------------- (Name of Issuer) COMMON STOCK - $.005 PAR VALUE 744375106 ----------------------------------------------------- (CUSIP Number) DECEMBER 31, 1999 ----------------------------------------------------- Date of Event which requires filing of this statement Check the appropriate box to designate the rule pursuant to which this schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [x] Rule 13d-1(d) Page 1 of 6 Pages 2 CUSIP No. 744375106 Page 2 of 6 pages --------- --- --- SCHEDULE 13G - -------------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS; S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS WERNER A. BAUMGARTNER - -------------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- (3) SEC USE ONLY - -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - -------------------------------------------------------------------------------- (5) SOLE VOTING POWER 56,200 NUMBER OF ------------------------------------------------------- SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 1,040,320 EACH ------------------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON WITH 56,200 ------------------------------------------------------- (8) SHARED DISPOSITIVE POWER 1,040,320 - -------------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,096,520 - -------------------------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% - -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- 3 CUSIP No. 744375106 Page 3 of 6 pages --------- --- --- SCHEDULE 13G - -------------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS; S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS ANNETTE BAUMGARTNER - -------------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- (3) SEC USE ONLY - -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION ------------------------------------------------------ NUMBER OF (5) SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------ EACH (6) SHARED VOTING POWER REPORTING PERSON 1,040,320 WITH ------------------------------------------------------ (7) SOLE DISPOSITIVE POWER 0 ------------------------------------------------------ (8) SHARED DISPOSITIVE POWER 1,040,320 - -------------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,040,320 - -------------------------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.8% - -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- 4 CUSIP No. 744375106 Page 4 of 6 pages --------- --- --- SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G AMENDMENT NO. 12 Item 1(a) Name of Issuer: Psychemedics Corporation (b) Address of Issuer's Principal Executive Offices: 1280 Massachusetts Avenue Cambridge, Massachusetts 02138 Item 2(a) Name of Person Filing: Werner and Annette Baumgartner (b) Address of Principal Business Office or, if none, Residence: 5832 Uplander Way Culver City, CA 90230 (c) Citizenship: USA (d) Title of Class of Securities, Common Stock, $.005 par value (e) CUSIP NUMBER: 744375106 Item 3 If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: Not Applicable Item 4 Amount Beneficially Owned: Dr. Baumgartner is the beneficial owner of 0 shares of Common Stock of the issuer and options to acquire 56,200 shares of Common Stock of the issuer. Dr. and Mrs. Baumgartner are trustees of a family trust and a charitable trust which own an aggregate of 1,040,320 shares of Common Stock of the issuer. The Baumgartners together beneficially own an aggregate of 1,096,520 shares of Common Stock of the issuer, representing 5.0% of the outstanding shares of the issuer. 5 CUSIP No. 744375106 Page 5 of 6 pages --------- --- --- Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. During 1999, Annette Baumgartner's percentage interest in the issuer dropped below five percent. Future filings will be made solely by Werner A Baumgartner. Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable Item 8 Identification and Classification of Members of the Group: This Schedule 13G/A is being filed by Werner and Annette Baumgartner. Dr. and Mrs. Baumgartner each expressly disclaims beneficial ownership of the securities held by the other, and each disclaims the existence of a group. Item 9 Notice of Dissolution of Group: Not Applicable Item 10 Certification Not Applicable 6 CUSIP No. 744375106 Page 6 of 6 pages --------- --- --- After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct. February 8, 2000 ------------------------------------- Date /S/ Werner A. Baumgartner ------------------------------------- Signature Werner A. Baumgartner ------------------------------------- Name/Title /S/ Annette Baumgartner ------------------------------------- Signature Annette Baumgartner ------------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----